Wolverine Trading’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,973
Closed -$217K 5576
2025
Q1
$212K Buy
+10,973
New +$321K ﹤0.01% 3898
2024
Q4
Sell
-5,770
Closed -$195K 5866
2024
Q3
$245K Buy
+5,770
New +$245K ﹤0.01% 3842
2023
Q1
Sell
-6,775
Closed -$305K 4950
2022
Q4
$305K Sell
6,775
-1,200
-15% -$54.3K ﹤0.01% 2743
2022
Q3
$397K Buy
7,975
+4,497
+129% +$247K ﹤0.01% 2868
2022
Q2
$209K Sell
3,478
-3,959
-53% -$325K ﹤0.01% 3495
2022
Q1
$868K Buy
+7,437
New +$868K ﹤0.01% 2590
2021
Q3
Sell
-4,412
Closed -$486K 6963
2021
Q2
$442K Sell
4,412
-3,451
-44% -$308K ﹤0.01% 3866
2021
Q1
$668K Buy
+7,863
New +$731K ﹤0.01% 3301
2020
Q3
Sell
-7,527
Closed -$791K 5145
2020
Q2
$661K Sell
7,527
-1,747
-19% -$139K ﹤0.01% 2430
2020
Q1
$631K Buy
+9,274
New +$650K ﹤0.01% 2408
2019
Q4
Sell
-5,270
Closed -$310K 5208
2019
Q3
$310K Buy
5,270
+798
+18% +$50.9K ﹤0.01% 3129
2019
Q2
$289K Sell
4,472
-23,130
-84% -$1.49M ﹤0.01% 3307
2019
Q1
$1.75M Buy
27,602
+3,309
+14% +$174K 0.01% 1639
2018
Q4
$906K Sell
24,293
-69,202
-74% -$2.44M ﹤0.01% 2057
2018
Q3
$4M Buy
+93,495
New +$3.27M 0.01% 1126
2017
Q3
Sell
-2,079
Closed -$17K 5040
2017
Q2
$17K Sell
2,079
-420
-17% -$3.88K ﹤0.01% 4158
2017
Q1
$30K Buy
+2,499
New +$54.6K ﹤0.01% 4065

Other funds holding TNDM

Wolverine Trading's TNDM Position: Q2 2025 in Review

Wolverine Trading sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 10,973 shares — an estimated $217K sold.

Wolverine Trading first reported a position in TNDM in Q1 2017 and held it in 17 quarters. The position peaked at $4M in Q3 2018. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Wolverine Trading reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,973 Tandem Diabetes Care shares in Q2 2025, an estimated $217K.
  • Wolverine Trading first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 17 quarters.
  • Wolverine Trading's Tandem Diabetes Care position peaked at $4M in Q3 2018.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.